Cannabis and its component cannabinoids (particularly tetrahydrocannabinol (D9-THC), believed to be the major active cannabinoid) have been claimed anecdotally to improve symptoms related to multiple sclerosis (MS), although until recently there has been little scientific evidence of effect. There is also experimental evidence that cannabinoids may have a neuroprotective action.
